SYNERGY™ XD H7493941808400Recalls & reported problems
Boston Scientific Corporation · Everolimus-Eluting Platinum Chromium Coronary Stent System · Class 3 · Implant
All models of SYNERGY XD (65)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 08714729981107), received between Nov 3, 2021 and May 27, 2025 — classified as 1 injury, 3 malfunctions.
The most frequently reported specific device problem is “Break” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Break2
- Device Dislodged or Dislocated1
- Failure to Advance1
- Material Integrity Problem1
Patient problems
- No Clinical Signs, Symptoms or Conditions4
- Non specific EKG/ECG Changes1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
MalfunctionMay 27, 2025Break; Break
IT WAS REPORTED THAT SHAFT BREAK OCCURRED. A 4.00 X 8MM SYNERGY? XD DRUG-ELUTING STENT WAS ADVANCED AND INSERTED OVER THE WIRE INTO A NON-BOSTON SCIENTIFIC GUIDE. HOWEVER, THE SHAFT WAS BROKEN FOR ABOUT 18 INCHES FROM THE HUB. THE DEVICE WAS PULLED OUT TOGETHER WITH THE WHOLE SYSTEM AND THE PROCEDURE WAS COMPLETED WITH ANOTHER SYNERGY DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22087097 ↗MalfunctionFeb 1, 2024Break; Material Integrity Problem; Break; Material Integrity Problem
IT WAS REPORTED THAT SHAFT HOLE AND BREAK OCCURRED. A 4.00 X 8MM SYNERGY XD DRUG-ELUTING STENT WAS SELECTED FOR USE. DURING ATTEMPTED LOADING, THE GUIDEWIRE EXITED THE SHAFT AND THE BALLOON, AND THE DEVICE FRACTURED. THE PROCEDURE WAS COMPLETED WITH A DIFFERENT DEVICE. THERE WERE NO PATIENT COMPLICATIONS REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18625807 ↗InjuryAug 15, 2022Device Dislodged or Dislocated; Device Dislodged or Dislocated
IT WAS REPORTED THAT STENT DISLODGEMENT OCCURRED. THE 90% STENOSED, TARGET LESION WAS LOCATED IN THE MILDLY TORTUOUS AND MODERATELY CALCIFIED RIGHT CORONARY ARTERY. A 4.00 X 8MM SYNERGY XD DRUG-ELUTING STENT WAS ADVANCED FOR TREATMENT. UPON REPOSITIONING, THE STENT WAS DISLODGED. THE STENT WAS CRUSHED TO THE SIDE WALL OF THE VESSEL AND THE PROCEDURE COMPLETED SUCCESSFULLY WITH A 3.75X12 NC EMERGE BALLOON CATHETER. THERE WERE NO PATIENT COMPLICATIONS.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15229486 ↗MalfunctionNov 3, 2021Failure to Advance; Failure to Advance
IT WAS REPORTED THAT FAILURE TO ADVANCE OCCURRED. A 4.00 X 8MM SYNERGY XD DRUG-ELUTING STENT WAS ADVANCED FOR TREATMENT. HOWEVER, DURING THE PROCEDURE, FAILED TO CROSS THE LESION AND ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI) OCCURRED. NO FURTHER INFORMATION WAS PROVIDED. IT WAS FURTHER REPORTED THAT THE NO CROSS EVENT DID NOT CAUSE THE STEMI.
Patient problems: No Clinical Signs, Symptoms or Conditions; Non specific EKG/ECG Changes
MAUDE report 12745340 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page